Compare Deutsche Bank AG (DB) vs Stryker Corporation (SYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Deutsche Bank AG vs Stryker Corporation — how do they compare? Deutsche Bank AG trades at $39.13 (market cap $71.96B), while Stryker Corporation trades at $345.59 (market cap $133.54B). The key difference: Stryker Corporation is the larger of the two by market cap, and Deutsche Bank AG pays the higher dividend (3.04%). Which is the better fit depends on your goals.
| DB | SYK | |
|---|---|---|
Market Cap | $71.96B | $133.54B |
Sector | Financials | Technology |
52-Week High | $40.33 | $394.34 |
52-Week Low | $28.37 | $282.58 |
Dividend Yield | 3.04% | 1.01% |
Enterprise Value | — | $145.01B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Deutsche Bank (DB) trades at $38.51, up 0.63% today, with a bullish technical signal from moving averages. The stock shows strong fundamentals: a low P/E of 10.07 and P/B of 0.79, with net income margin improving to 21.59% in 2025. Recent Q2 2026 earnings missed estimates but revenue growth remains robust, supported by a new share buyback plan and its role as a renminbi clearing bank in China, as reported by Reuters on August 10, 2026.
The outlook is mixed: valuation discounts and earnings beats in three of the last four quarters signal upside potential, but a neutral analyst consensus (57.58% hold) and regulatory risks from tax investigations pose headwinds. Investors should weigh strong operational cash flow of $47.06B in 2025 against volatile net income trends and high RSI levels indicating overbought conditions.
Stryker (SYK) trades at $347.21, up 0.4% today, with a bullish technical outlook supported by moving averages. The stock shows strong fundamentals, including a 9% organic sales growth in Q2 2026 and a net income margin of 14.43%. Recent news highlights recovery from a cybersecurity incident and the launch of Mako RPS, expanding its robotic surgery portfolio. Analyst consensus is overwhelmingly positive, with 74% recommending Buy and a price target of $379.44.
The outlook for SYK is favorable, driven by robust earnings growth and strategic product launches. Key risks include cybersecurity vulnerabilities and margin pressures from tariffs. With no sell ratings and strong institutional support, the stock presents a compelling opportunity for growth-oriented investors, though monitoring quarterly execution remains critical.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Deutsche Bank AG
In July 2019, Deutsche Bank announced another restructuring plan hoping to revitalize revenue, reduce costs, and return to profitability. The largest moving pieces of the new plan is the full exit of global equity sales & trading, the scaling back of its fixed income business, as well as 18,000 FTE reductions until 2022. The remaining core business segments include private banking, corporate banking, asset management, and investment banking.
Read more on DB →About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →
